These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26689510)

  • 1. Characterization of reactive stroma in prostate cancer: involvement of growth factors, metalloproteinase matrix, sexual hormones receptors and prostatic stem cells.
    Silva MM; Matheus WE; Garcia PV; Stopiglia RM; Billis A; Ferreira U; Fávaro WJ
    Int Braz J Urol; 2015; 41(5):849-58. PubMed ID: 26689510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
    Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
    Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
    Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
    Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma on needle prostatic biopsies: does reactive stroma predicts biochemical recurrence in patients following radical prostatectomy?
    Billis A; Meirelles L; Freitas LL; Polidoro AS; Fernandes HA; Padilha MM; Magna LA; Reis LO; Ferreira U
    Int Braz J Urol; 2013; 39(3):320-7. PubMed ID: 23849565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z; Wenlv S
    Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential value of (Myo)fibroblastic stromal reaction in the diagnosis of prostatic adenocarcinoma.
    Tomas D; Kruslin B
    Prostate; 2004 Dec; 61(4):324-31. PubMed ID: 15389817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor, estrogen, and prolactin receptor features in different grades of prostatic adenocarcinoma in elderly men.
    Hetzl AC; Montico F; Lorencini RM; Kido L; Cândido E; Billis A; Ferreira U; Cagnon VH
    Microsc Res Tech; 2013 Mar; 76(3):321-30. PubMed ID: 23362007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
    Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
    Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of prostate stem cell antigen (PSCA) in prostate cancer: a tissue microarray study of Iranian patients.
    Taeb J; Asgari M; Abolhasani M; Farajollahi MM; Madjd Z
    Pathol Res Pract; 2014 Jan; 210(1):18-23. PubMed ID: 24183365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer.
    Henshall SM; Quinn DI; Lee CS; Head DR; Golovsky D; Brenner PC; Delprado W; Stricker PD; Grygiel JJ; Sutherland RL
    Cancer Res; 2001 Jan; 61(2):423-7. PubMed ID: 11212224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periacinar retraction clefting in nonneoplastic and neoplastic prostatic glands: artifact or molecular involvement.
    Fávaro WJ; Hetzl AC; Reis LO; Ferreira U; Billis A; Cagnon VH
    Pathol Oncol Res; 2012 Apr; 18(2):285-92. PubMed ID: 21912906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen Receptor Gene Copy Number and Protein Expression in Treatment-Naïve Prostate Cancer.
    Poelaert F; Kumps C; Lumen N; Verschuere S; Libbrecht L; Praet M; Rottey S; Claeys T; Ost P; Decaestecker K; De Meerleer G; Van Praet C
    Urol Int; 2017; 99(2):222-228. PubMed ID: 28052297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone receptor expression during prostate cancer progression suggests a role of this receptor in stromal cell differentiation.
    Yu Y; Yang O; Fazli L; Rennie PS; Gleave ME; Dong X
    Prostate; 2015 Jul; 75(10):1043-50. PubMed ID: 25833156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
    Giri D; Ropiquet F; Ittmann M
    Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
    Ayala G; Tuxhorn JA; Wheeler TM; Frolov A; Scardino PT; Ohori M; Wheeler M; Spitler J; Rowley DR
    Clin Cancer Res; 2003 Oct; 9(13):4792-801. PubMed ID: 14581350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and prostate cancer: correlation with Gleason score.
    Correa LL; Neto LV; Lima GA; Gabrich R; Miranda LC; Gadelha MR
    Int Braz J Urol; 2015; 41(1):110-5. PubMed ID: 25928516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.
    Tidehag V; Hammarsten P; Egevad L; Granfors T; Stattin P; Leanderson T; Wikström P; Josefsson A; Hägglöf C; Bergh A
    Eur J Cancer; 2014 Jul; 50(10):1829-1835. PubMed ID: 24726733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
    Zhigang Z; Wenlu S
    Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity of stromal changes is associated with tumor relapse in clinically advanced prostate cancer after castration therapy.
    Wu JP; Huang WB; Zhou H; Xu LW; Zhao JH; Zhu JG; Su JH; Sun HB
    Asian J Androl; 2014; 16(5):710-4. PubMed ID: 24875819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.